Dipeptidyl Peptidase-4 Inhibitor Reduces the Risk of Developing Hypertrophic Scars and Keloids following Median Sternotomy in Diabetic Patients: A Nationwide Retrospective Cohort Study Using the National Database of Health Insurance Claims of Japan

Plast Reconstr Surg. 2021 Jun 1;147(6):1067e-1068e. doi: 10.1097/PRS.0000000000007935.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Cicatrix, Hypertrophic* / etiology
  • Cicatrix, Hypertrophic* / pathology
  • Cicatrix, Hypertrophic* / prevention & control
  • Diabetes Mellitus*
  • Dipeptidyl-Peptidase IV Inhibitors*
  • Dipeptidyl-Peptidases and Tripeptidyl-Peptidases
  • Humans
  • Insurance, Health
  • Japan / epidemiology
  • Keloid* / etiology
  • Keloid* / pathology
  • Keloid* / prevention & control
  • Retrospective Studies
  • Sternotomy

Substances

  • Dipeptidyl-Peptidase IV Inhibitors
  • Dipeptidyl-Peptidases and Tripeptidyl-Peptidases